PEN vs PHG Stock Comparison

PHG currently leads PEN in this stock comparison, with AIQ scores of 72 vs 66. The clearest difference is value, while PEN has the stronger risk resilience profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 6 points
PEN
Healthcare
vs
PHG
Healthcare
PEN
Penumbra, Inc.
Price
$321
Day move
+0.47%
AIQ Score
66/100
Best edge
Risk Resilience
Sector
Healthcare
PHG
Koninklijke Philips N.V.
Leads
Price
$29.81
Day move
-0.27%
AIQ Score
72/100
Best edge
Value
Sector
Healthcare

What is the main difference between PEN and PHG?

PHG leads the current stock comparison as Koninklijke Philips N.V., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Penumbra, Inc. vs Koninklijke Philips N.V.

Data as of Nov 18, 2026· market close· Healthcare· Coverage 58/66 fields· Moderate confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

PHG leads

PHG leads by 6 AIQ points, primarily on Value and Momentum, having only recently taken the lead back from PEN.

Fragile: 3 of 5 evidence groups support PHG, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Reversed
PEN

Penumbra, Inc.

AIQ Score
66/100
AIQ Edge Score
8/10
PHG

Koninklijke Philips N.V.

Leads
AIQ Score
72/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors PHG over PEN, 72 versus 66 as of Nov 18, 2026. PHG's advantage is driven primarily by stronger value and momentum, while PEN holds the stronger risk resilience profile. PHG also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor PHG today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. PHG lead: Reversed — PEN led by 4 AIQ points 30 sessions ago; PHG now leads by 6.

Compare Penumbra, Inc. and Koninklijke Philips N.V. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

PEN
+23.4%
PHG
-11.1%

Total return comparison

Growth of $10,000, distributions reinvested

PEN $12,344 · PHG $8,887

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare PEN and PHG against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PEN advantage
0
PHG advantage
  • Value48 vs 80
    PHG +32
  • Risk Resilience92 vs 73
    PEN +19
  • Momentum56 vs 72
    PHG +16
  • Quality78 vs 67
    PEN +11

3 of 5 evidence groups favor PHG. PHG’s edge is concentrated in value and momentum; PEN keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

PEN0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
PHG0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • RSI Overbought — bearish, momentum, short horizon

PHG's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — PEN and PHG both carry a full feed there.

The central trade-off

PHG (Koninklijke Philips N.V.): the stronger current systematic profile, led by value and momentum.

PEN (Penumbra, Inc.): the counter-case, on risk resilience, quality, fundamentals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PHG

PHG on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PEN

PEN on combined revenue and EPS growth.

Value

PHG

PHG on the peer-relative Value factor, by 32 points.

Momentum

PHG

PHG on the Momentum factor, by 16 points.

Lower downside

PEN

PEN on Risk Resilience, by 19 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor PHG. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScorePHG66 vs 72
FundamentalsPENEPS growth 21.6% vs -93.1%; TTM ROE 2.7% vs 0.2%; gross margin 68% vs 46.4%; operating margin 12.1% vs 10.9%
ValuationPHGValue 48 vs 80
TechnicalsPHGPrice vs 50-day 0.1% vs 14%; vs 200-day -1.5% vs 11.4%
Risk ResiliencePENRisk Resilience 92 vs 73
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PEN and PHG and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 6 points.
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PHG.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

PHG lead: Reversed — PEN led by 4 AIQ points 30 sessions ago; PHG now leads by 6.

Jun 1PEN leads above the line · PHG leads belowNov 18
Today
PHG +6
66 vs 72
7 sessions ago
PHG +7
66 vs 73
30 sessions ago
PEN +4
67 vs 63
90 sessions ago
PEN +1
61 vs 60

The lead changed hands 3 times in this window, most recently on Oct 28 when PHG moved ahead of PEN.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PENConflicted

2 bullish / 3 bearish / 4 neutral, conflicted

Only PEN

  • Bollinger Band Squeeze — neutral, volatility, short horizon (2.5%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Contraction - Coiling — neutral, volatility, short horizon (0.79%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-2.7%)
  • EMA Ribbon Compression — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
PHGConflicted

3 bullish / 2 bearish / 1 neutral, conflicted

Only PHG

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • RSI Overbought — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: Death Cross Active, EMA Ribbon Expansion Bullish.

PHG leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PENNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.47%, AIQ 0 points).

PHGNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.27%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PEN closes the Value gap — currently 32 points behind, the largest single contributor to PHG's edge.
  2. 2PEN's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PEN leads on balance
MetricPENPHG
Revenue growth (YoY)5.2%0.2%
EPS growth (YoY)21.6%-93.1%
Gross margin68%46.4%
Operating margin12.1%10.9%
Return on equity (TTM)2.7%0.2%
Debt to equity0.130.7

Performance

PHG leads 4 of 6 windows
MetricPENPHG
1 week (5 sessions)0.5%0%
1 month (20 sessions)0%17.9%
3 months (63 sessions)-1.9%13.1%
6 months (126 sessions)-0.4%20.3%
Year to date3.2%12%
1 year (252 sessions)14.5%3.3%

Technicals

PHG has the stronger structure
MetricPENPHG
RSI (14)49.570.9
ADX (14)1743.2
Price vs 50-day0.1%14%
Price vs 200-day-1.5%11.4%
Volatility (1M, annualized)10.9%38.9%

Risk

PEN is the more resilient
MetricPENPHG
Beta0.190.85
Sharpe ratio0.620.18
Sortino ratio1.150.27
Max drawdown-12.2%-27.7%
Current drawdown-10.7%-7.8%
Annualized volatility19.5%29.7%
Value at risk (95%)-0.9%-2.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PEN or PHG?

On the Algovestiq AIQ Score, PHG is the stronger of the two as of Nov 18, 2026, scoring 72 against PEN's 66. The edge comes from value and momentum. PEN is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PEN or PHG the better buy right now?

PHG carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.

Why does the AIQ Score favor PHG over PEN?

The composite weights Quality, Value, Momentum and Risk Resilience. PHG leads Value by 32 points; PEN leads Risk Resilience by 19 points; PHG leads Momentum by 16 points. Where the two split, the factor with the larger weight carries the result.

Which is better value, PEN or PHG?

PHG is the better-valued of the two on the peer-relative Value factor. PHG on the peer-relative Value factor, by 32 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PEN or PHG?

PEN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PEN or PHG?

PHG on the Momentum factor, by 16 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PEN or PHG?

PEN is the more resilient of the two, so the other name carries the higher downside risk. PEN on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PEN more profitable than PHG?

PEN leads on the comparable margin measures — gross margin 68% vs 46.4%; operating margin 12.1% vs 10.9%; ttm roe 2.7% vs 0.2%.

Is PHG's lead over PEN getting stronger or weaker?

PHG lead: Reversed — PEN led by 4 AIQ points 30 sessions ago; PHG now leads by 6. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has changed hands 3 times in that window, most recently on 2026-10-28, when PHG moved ahead of PEN.

What would change the PEN vs PHG verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PEN closes the Value gap — currently 32 points behind, the largest single contributor to PHG's edge; PEN's Death Cross Active resolves — a bearish trend rule currently active against it; PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PEN and PHG?

PEN: 2 bullish / 3 bearish / 4 neutral, conflicted. PHG: 3 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PEN is Death Cross Active (bearish, long horizon). On PHG it is Death Cross Active (bearish, long horizon).

Compare PEN and PHG with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.